Page last updated: 2024-08-18

4-butyrolactone and (3,4-dihydroxyphenylamino)-2-imidazoline

4-butyrolactone has been researched along with (3,4-dihydroxyphenylamino)-2-imidazoline in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Horn, AS; Houwing, HA; van Oene, JC	1

Other Studies

1 other study(ies) available for 4-butyrolactone and (3,4-dihydroxyphenylamino)-2-imidazoline

Article	Year
Evidence that the purported dopaminergic agonist (3,4-dihydroxyphenylimino)-2-imidazolidine (DPI) may reduce rat striatal dopamine turnover by an alpha 2-adrenergic mechanism. European journal of pharmacology, 1982, Jun-16, Volume: 81, Issue:1 Topics: 4-Butyrolactone; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Catecholamines; Catechols; Clonidine; Corpus Striatum; Dopamine; Female; Imidazolines; Male; Norepinephrine; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Receptors, Dopamine	1982

Article

Year

Evidence that the purported dopaminergic agonist (3,4-dihydroxyphenylimino)-2-imidazolidine (DPI) may reduce rat striatal dopamine turnover by an alpha 2-adrenergic mechanism.

European journal of pharmacology, 1982, Jun-16, Volume: 81, Issue:1

Topics: 4-Butyrolactone; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Catecholamines; Catechols; Clonidine; Corpus Striatum; Dopamine; Female; Imidazolines; Male; Norepinephrine; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Receptors, Dopamine

1982